Close Menu
Home » Apogenix Awarded €3M Grant to Test Brain Cancer Drug Companion Dx

Apogenix Awarded €3M Grant to Test Brain Cancer Drug Companion Dx

Feb 16, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Biopharmaceutical firm Apogenix announced today that it has received a €3 million ($3.4 million) grant from the German Federal Ministry of Education and Research to support its ongoing development of a companion diagnostic for its experimental glioblastoma immunotherapy APG101.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Snakes and Bats and People

An initial analysis suggests the novel coronavirus from Wuhan that is sickening people might come from snakes, a team of virologists writes at the Conversation.

Coyote Match in Chicago

DNA testing confirms captured Chicago coyote same as the one that bit a boy near a nature museum, the Chicago Tribune reports.

Viruses on Ice

An analysis of Tibetan ice cores uncovers more than two dozen previously unknown virus groups, LiveScience reports.

Nature Papers Examine Ancient Human DNA From Africa, Present Approach to Study Microbiota

In Nature this week: genomic analysis of four children buried in Cameroon approximately 3,000 and 8,000 years ago, and more.

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

What's Popular?

In Molecular Diagnostics

  1. Quest Diagnostics Acquires Blueprint Genetics

  2. Myriad Genetics Seeks Supplemental Approval of HRD Test as CDx for GSK Ovarian Cancer Drug

  3. B Cell Gene Expression Profiling May Enable Cancer Immunotherapy CDx Test

    Premium

  4. Sysmex Wins Chinese Approval for Breast Cancer IVD Reagent

  5. Abbott Q4 Diagnostics Revenues up 5 Percent, MDx Revenues Decline

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.